Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Practical material

SDR-PEP Implementation - Standard Operating Procedures (SOPs)

NLR . 2023;
Publication

Leprosy.

The Independent practitioner. 1881; 2 (3) : 116.
Download PDF
Publication

Filhos e Comunicantes: a construção do problema da proximidade com osdoentes de hanseníase na legislação.

da Silva L. F. Revista Desenvolvimento Socioeconomico em debate. 2023; 9 (2) : 22-40.
Download PDF
Publication

Aspectos imunológicos das reações hansenícas: uma overview

Rodrigues MLC, Drummond Júnior DG, Ungaro A, et al. South Florida Publishing LLC. CONTRIBUCIONES A LAS CIENCIAS SOCIALES. 2023; 16 (10) : 22131-22148.
Download PDF
Publication

Molecular Characterization in 3D Structure of MicroRNA Expressed in Leprosy

Andrade LJDO, Jesus HBD, Oliveira LMD, et al. Universidade Federal da Bahia. Revista de Ciências Médicas e Biológicas. 2023; 22 (2) : 188-196.
Download PDF
Publication

Analysis Mycobacterium lepromatosis as the causative agent of diffuse lepromatous leprosy patient in Indonesia

Alinda MD, KARIM A, PUTRA BHK, et al. UNS Solo. Biodiversitas Journal of Biological Diversity. 2023;
Download PDF
Publication

Overview of leprosy, including the diagnosis and current available treatments

Srivastav Y, Prajapati A, Jaiswal A, et al. South Asian Academic Publications. Journal of Innovations in Applied Pharmaceutical Science (JIAPS). 2023;
Download PDF
Publication

Avaliação da import ncia de testes rápidos no diagnóstico precoce da hanseníase e seu papel na promoção da saúde pública

Sousa MCCD, SILVA MARD, VIDAL TIR, et al. Revista Multidisciplinar em Saúde. Anais do IV Congresso Nacional de Inovações em Saúde. 2023;
Download PDF
Publication

Psychological Interventions in Psychodermatological Practice

Latheef ENA, Hafi BNA. Medknow. Clinical Dermatology Review. 2023; 7 (4) : 333-337.
Download PDF
Publication

Do Systemic Steroids Given for Lepra Reactions Increase the Risk of Relapse after Release from Treatment?: A 10 year Retrospective Study from a Tertiary Care Centre

Nair S. P, Viswanath V. Hind Kusht Nivaran Sangh. Indian Journal of Leprosy. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 125
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD